Insider Ledger

STLN insider buying and SEC filings, explained

Oncology Institute, Inc. · CIK 1799191

Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov

Insider activity in the last 12 months

Bought
$2.7M
Insiders who bought
1
Sold (not marked 10b5-1)
$251K
Planned sales (10b5-1)
$2.6M

Insider purchases and sales, last 12 months

TradedTypeWhat was filedSource
Aug 21, 2026Planned (10b5-1)Brad Hively (Director) sold 298,853 shares at about $6.51 ($1.9M), marked as a 10b5-1 plan trade. Holdings down 42% to 411,976 shares.SEC filing
Filed Aug 24, 2026
Aug 14, 2026Purchase (code P)Jorey Chernett (10% owner) bought 12,000 shares at $6.54 ($78K), reported as a purchase (code P). Holdings up <1% to 10,660,858 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Aug 17, 2026
Jul 21, 2026Purchase (code P)Jorey Chernett (10% owner) bought 18,000 shares at about $5.27 ($95K), reported as a purchase (code P). Holdings up <1% to 10,648,858 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Jul 22, 2026
Jul 14, 2026Planned (10b5-1)Yale Podnos (Chief Medical Officer) sold 23,452 shares at about $6.41 ($150K), marked as a 10b5-1 plan trade. Holdings down 8% to 259,527 shares.SEC filing
Filed Jul 16, 2026
Jul 10, 2026Purchase (code P)Jorey Chernett (10% owner) bought 15,000 shares at about $5.85 ($88K), reported as a purchase (code P). Holdings up <1% to 10,630,858 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Jul 13, 2026
Jun 23, 2026Purchase (code P)Jorey Chernett (10% owner) bought 18,000 shares at about $5.02 ($90K), reported as a purchase (code P). Holdings up <1% to 10,615,858 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Jun 24, 2026
Jun 8, 2026Planned (10b5-1)Yale Podnos (Chief Medical Officer) sold 23,451 shares at about $5.38 ($126K), marked as a 10b5-1 plan trade. Holdings down 8% to 259,527 shares.SEC filing
Filed Jun 9, 2026
Jun 4, 2026Purchase (code P)Jorey Chernett (10% owner) bought 12,000 shares at $4.75 ($57K), reported as a purchase (code P). Holdings up <1% to 10,579,858 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Jun 5, 2026
May 19–20, 2026Purchase (code P)Jorey Chernett (10% owner) bought 38,500 shares between May 19 and May 20 at about $4.07 ($157K), reported as a purchase (code P). Holdings up <1% to 10,567,858 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed May 21, 2026
May 19, 2026Purchase (code P)Jorey Chernett (10% owner) bought 30,000 shares at $4.09 ($123K), reported as a purchase (code P). Holdings up <1% to 10,529,358 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed May 20, 2026
Apr 14–16, 2026Planned (10b5-1)Mohit Kaushal (Director) sold 95,719 shares between Apr 14 and Apr 16 at about $3.50 ($335K), marked as a 10b5-1 plan trade. Holdings down 36% to 172,583 shares.SEC filing
Filed Apr 16, 2026
Apr 9, 2026Purchase (code P)Jorey Chernett (10% owner) bought 20,000 shares at $3.10 ($62K), reported as a purchase (code P). Holdings up <1% to 10,499,358 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Apr 13, 2026
Mar 27, 2026Purchase (code P)Jorey Chernett (10% owner) bought 27,429 shares at $2.96 ($81K), reported as a purchase (code P). Holdings up <1% to 10,479,358 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Mar 30, 2026
Mar 26, 2026Purchase (code P)Jorey Chernett (10% owner) bought 50,000 shares at about $3.15 ($158K), reported as a purchase (code P). Holdings up <1% to 10,451,929 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Mar 27, 2026
Mar 24, 2026Purchase (code P)Jorey Chernett (10% owner) bought 125,000 shares at about $3.11 ($389K), reported as a purchase (code P). Holdings up 1% to 10,401,929 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Mar 25, 2026
Mar 20, 2026Purchase (code P)Jorey Chernett (10% owner) bought 25,000 shares at about $3.35 ($84K), reported as a purchase (code P). Holdings up <1% to 10,276,929 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Mar 23, 2026
Mar 13–17, 2026Purchase (code P)Jorey Chernett (10% owner) bought 398,985 shares between Mar 13 and Mar 17 at about $3.07 ($1.2M), reported as a purchase (code P). Holdings up 4% to 10,251,929 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Mar 17, 2026
Jan 2, 2026SaleRobert Ross Carter (CFO) sold 247 shares at $3.56 ($879). Holdings down <1% to 235,122 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Jan 5, 2026
Dec 15, 2025SaleBrad Hively (Director) sold 13,333 shares at about $3.77 ($50K). Holdings down 2% to 683,721 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Dec 16, 2025
Nov 18, 2025SaleMark L Pacala (Director) sold 50,000 shares at $4.00 ($200K). Holdings down 22% to 174,971 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Nov 20, 2025

36 routine transactions (such as grants, option exercises or tax withholding) are not listed.

Cluster buys

No cluster buys in the last 12 months.

Red flags

No red flags in the last 12 months.

Key events

No key events in the last 12 months.

8-K filings, last 12 months

No 8-K filings in the last 12 months.

Red flags are objective triggers only: the item or form filed, never an opinion.

Follow STLN in the Insider Ledger app

A plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.

Get the app